(Rac)-Zevaquenabant

Overview

(Rac)-Zevaquenabant ((Rac)-MRI-1867, compound 6b) is a cannabinoid receptor type 1 (CB 1 R)/iNOS antagonist, with a K i of 5.7 nM for CB 1 R. (Rac)-Zevaquenabant is potential for the research of liver fibrosis.

Application

Products | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Pain | Products > Disease Areas > Obesity | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Respiratory Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Others | Products > Signaling Pathways > Cannabinoid Receptor | Products > Signaling Pathways > NO Synthase

Product Information

• Catalog No.: HY-141411
• CAS No.: 1610420-28-4
• Molecular Formula: C25H21ClF3N5O2S
• Molecular Weight: 547.98
• Purity: 99.20%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (4.56 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source